Welcome to the 4th GxP Cloud Compliance Summit
The release of the FDA’s new CSA guidance offers life science companies the opportunity to fully capitalize on the advantages of cloud computing - from enhanced resource pooling to expense reduction and rapid scalability. But with the implementation of new guidelines and new systems, come new challenges!

Vigilance is imperative around testing and validating your cloud to ensure patient privacy, data security, and quality practices, in addition to creating traceable records of every test and result to present to an auditor. With this in mind, if you're wondering how to simplify validating your cloud in line with CSA and in a way that saves you both time and money, don't miss this solutions-focused conference!